Maintenance treatment with balsalazide provides more effective control of nocturnal symptoms of ulcerative colitis (UC) than delayed-release mesalazine

Authors :: K. J. Schofield
C. D. Holdsworth
Jrb Green
G. D. Kerr
John Gibson
Alan J Lobo
J. P. Crowe
E. T. Swarbrick
Taylor
Source :: Gastroenterology. 114:A987
Publication Year :: 1998
Publisher :: Elsevier BV, 1998.

Subjects :: medicine.medical_specialty
Hepatology
business.industry
Gastroenterology
Delayed release (linguistics)
Balsalazide
Nocturnal
medicine.disease
Ulcerative colitis
chemistry.chemical_compound
chemistry
Mesalazine
Internal medicine
medicine
business

Full Text Access

Tools